Stay updated with the latest chemotherapy news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on chemotherapy topics.
Coimbatore: There is an alarming rise in breast and cervical cancer cases in the district. If the data available with the 13 govt hospitals that screen for breast and cervical cancers in Coimbatore is anything to go by, the test positivity rate is steadily increasing by 2% to 4% every year. "Nowadays, women, irrespective of their age group, are vulnerable for breast and cervical cancers. Early menstruation, late menopause and obesity are major reasons for breast cancer. Women consuming excessive ...Read More >
Mumbai: Television star Hina Khan revealed her stage-three breast cancer diagnosis in June 2024. Through social media, she shared her journey, receiving praise for her strength and openness. Fans admired her positivity, but fellow actress Rozlyn Khan has questioned the accuracy of her claims. Hina claimed she underwent a 15-hour surgery and traveled extensively during chemotherapy. Rozlyn Khan said, "In Stage 3, surgery first, chemotherapy and then it comes to radiation. These are the procedure ...Read More >
NewsVoir Ahmedabad (Gujarat) [India], December 12: Ahmedabad University has built an innovative academic ecosystem, redefining the ways of learning through research-driven thinking, hands-on experiences, and interdisciplinary exploration. The University has reimagined the classroom experience to equip students to tackle complex global challenges that lie at the intersection of diverse disciplines - a foundation that not only shapes the future of education but also drives societal progress. The ...Read More >
First & only immuno-oncology drug approved by various regulatory authorities around the world Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. Toripalimab is a New Biological Entity (NBE). It is the only immuno-oncology drug approved by various regulatory authorities around the world such as United States Food and Drug Administration (USFDA), European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), and others for the treatment of adu ...Read More >
, /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in from National Medical (TASE:PMCN) Products Administration (NMPA) for the first domestically developed trophoblast cell-surface antigen 2 (TROP2)-directed antibody"drug conjugate (ADC) sacituzumab tirumotecan (sac-™T, formerly SKB264/MK-2870) for adult patients with unresectable locally advanced or metastatic triple negative breast cancer (TNBC) who ha ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.